HomeStrokeVol. 39, No. 11Interplay of Vascular Phenotype and Metabolic Phenotype in Populations With or Without Type 2 Diabetes Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBInterplay of Vascular Phenotype and Metabolic Phenotype in Populations With or Without Type 2 Diabetes Marijan Bosevski, MD Marijan BosevskiMarijan Bosevski University Heart Institute, Skopje, Macedonia Search for more papers by this author Originally published18 Sep 2008https://doi.org/10.1161/STROKEAHA.108.528372Stroke. 2008;39:e175Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: September 18, 2008: Previous Version 1 To the Editor:Recently, Dr Sourij and colleagues1 concluded that insulin resistance is one of the main factors for carotid atherosclerosis measured as intima-media thickness (IMT). There was evidence given in this article that HOMA index rather than Short Insulin Tolerance Test is associated with carotid IMT. HDL has been inversely related to carotid atherosclerosis by the Insulin Resistance Atheroscterosis Study (IRAS).2 Metabolic syndrome amplifies LDL-related increase of carotid IMT in the general population.3 Arterial hypertension and increased waist have been also related to carotid IMT.4,5Dehnavi in his study hypothesized that metabolic syndrome as clinical expression of insulin resistance, as well as low-grade systemic inflammation modify the extent of atherosclerosis in type 2 diabetes (T2DM).6 The study proved this thesis using sonographic measurements for carotid IMT for vascular phenotype determination. Ethiopathogenesis of carotid artery disease is a result of several factors: hiperinsulinemia, low HDL, high LDL, obesity and arterial hypertension.7–9 Individual constellation of metabolic syndrome predicts presence of carotid artery disease in a type 2 diabetes population.10Today there is no doubt that by targeting metabolic risk factors we reduce a global risk of patients with or without type 2 diabetes.11 Do we still need to estimate HOMA index, or is it necessary to estimate its clinical entity (metabolic syndrome)? What does Dr Sourij’s team mean by this?DisclosuresNone.1 Sourij H, Schmoelzer I, Dittrich P, Paulweber B, Iglseder B, Wascher TC. Insulin resistance as a risk factor for carotid atherosclerosis: a comparison of the homeostasis model assessment and the short insulin tolerance test. Stroke. 2008; 39: 1349–1351.LinkGoogle Scholar2 Wagenknecht LE, D'Agostino R Jr, Savage PJ, O'Leary DH, Saad MF, Haffner SM. Duration of diabetes and carotid wall thickness: The Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 1997; 28: 999–1005.CrossrefMedlineGoogle Scholar3 Kawamoto R, Tomita H, Oka Y, Kodama A, Kamitami A. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. Intern Med. 2005; 44: 1232–1238.CrossrefMedlineGoogle Scholar4 Rajala U, Laakso M, Paivansalo M. Low insulin sensitivity measured by both quantitative insulin sensitive check index and homeostasis model assessment method as a risk factor of increased intima-media thickness of the carotid artery. J Clin Endocrinol Metab. 2002; 87: 5092–5097.CrossrefMedlineGoogle Scholar5 Szernichow S, Bertrais S, Oppert JM, Galan P, Blacher J, Ducimetiere P, Hercberg S, Satar M, Zureik M. Body composition and after repartition in relation to structure and function of a large arteries in middle-aged adults (the SU.VI.MAX study). Int J Obes. 2005; 29: 826–832.CrossrefMedlineGoogle Scholar6 Dehnavi RA, Beishuizen ED, van de Ree MA, Le Cessie S, Huisman MV, Kluft C, Princen HM, Tamsma JT. The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus. Eur J Intern Med. 2008; 19: 115–121.CrossrefMedlineGoogle Scholar7 Williams R, Aiery M. Epidemiology and pathogenesis of diabetic angiopathy. In: Tooke J. Diabetic Angiopathy. London: Arnold; 1999.Google Scholar8 Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002; 287: 356–359.CrossrefMedlineGoogle Scholar9 Pollex R, Al-Shalli KZ, House AA, Spence JD, Fenster A, Mamakeesick M, Zinman B, Harris SB, Hanley AJ, Hegele RA. Relationship of metabolic syndrome to carotid ultrasound traits. Cardiovascular Ultrasound. 2006; 4: 28–35.CrossrefMedlineGoogle Scholar10 Bosevski M, Borozanov V, Georgievska-Ismail L. Influence of metabolic risk factors on the presence of carotid artery disease in patients with type 2 diabetes and coronary artery disease. Diab Vasc Dis Res. 2007; 4: 49–52.CrossrefMedlineGoogle Scholar11 Grant PJ. Diabetes mellitus and vascular disease: targeting cardiometabolic risk. Diab Vasc Dis Res. 2008; 5: 7–8.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails November 2008Vol 39, Issue 11 Advertisement Article InformationMetrics https://doi.org/10.1161/STROKEAHA.108.528372PMID: 18802203 Originally publishedSeptember 18, 2008 PDF download Advertisement
Read full abstract